Department of Clinical Neurosciences,Hotchkiss Brain Institute,University of Calgary,Calgary,Canada.
Int Psychogeriatr. 2018 Feb;30(2):273-280. doi: 10.1017/S1041610217001855. Epub 2017 Oct 11.
Mild behavioral impairment (MBI) is characterized by later life acquired, sustained, and impactful neuropsychiatric symptoms (NPS) of any severity that cannot be better accounted for by other formal medical and psychiatric nosology. MBI is an "at risk" state for incident cognitive decline and dementia, and for some, MBI is the index manifestation of neurodegeneration, observed in advance of cognitive impairment. Initially described in Frontotemporal Dementia (FTD), MBI evolved to describe a preclinical stage of all cause dementia, and has been operationalized in the International Society to Advance Alzheimer's Research and Treatment-Alzheimer's Association (ISTAART-AA) proposed research diagnostic criteria. Here, we describe three cases in which patients diagnosed with a variety of dementing conditions initially presented with NPS to the Cognitive Neurosciences Clinic at the University of Calgary, Canada. All patients described in our series were given a final diagnosis of dementia; the etiology supported by clinical, cognitive, and neuroimaging findings. In all three cases, the progression to dementia was preceded by NPS that meet criteria for MBI. With these examples, we are able to illustrate that MBI can represent a premonitory stage of dementia of different etiologies. These cases demonstrate early use of the MBI checklist (MBI-C). The cases presented in this series serve as examples of NPS as early manifestations of dementia. Our case examples include both FTD and AD, and demonstrate that before a diagnosis of a neurodegenerative disease is considered, often patients will be diagnosed with and treated for a psychiatric condition. These early NPS can be characterized within the domains outlined in the ISTAART-AA MBI criteria, and detected with the MBI-C, which may help clinicians consider neurodegenerative disease in the differential diagnosis of later life onset psychiatric symptomatology.
轻度行为障碍 (MBI) 的特点是在生命后期获得、持续存在且具有重大影响的神经精神症状 (NPS),这些症状不能用其他正式的医学和精神病学分类更好地解释。MBI 是认知能力下降和痴呆的“风险”状态,对于某些人来说,MBI 是神经退行性变的标志性表现,在认知障碍之前就已经观察到。MBI 最初在额颞叶痴呆 (FTD) 中描述,后来演变为描述所有原因痴呆的临床前阶段,并在国际推进阿尔茨海默病研究和治疗-阿尔茨海默病协会 (ISTAART-AA) 提出的研究诊断标准中得到实施。在这里,我们描述了三个病例,这些患者最初在加拿大卡尔加里大学认知神经科学诊所因 NPS 被诊断为各种痴呆症。我们系列中的所有患者都被诊断为痴呆症;病因由临床、认知和神经影像学发现支持。在所有三个病例中,痴呆的进展都先于符合 MBI 标准的 NPS。通过这些例子,我们能够说明 MBI 可以代表不同病因痴呆的前驱阶段。这些病例表明了 MBI 检查表 (MBI-C) 的早期使用。本系列中呈现的病例是 NPS 作为痴呆早期表现的例子。我们的病例包括 FTD 和 AD,表明在考虑诊断神经退行性疾病之前,通常患者将被诊断为并接受精神疾病的治疗。这些早期 NPS 可以用 ISTAART-AA MBI 标准中概述的领域来描述,并通过 MBI-C 来检测,这可能有助于临床医生在晚年出现的精神症状的鉴别诊断中考虑神经退行性疾病。